go to The Japanese Society of Gastroenterological Surgery official site The Japanese Journal of Gastroenterological Surgery Online Journal
go to main navigation
go to Home
go to Current Issue
go to Past Issue
go to Article Search
Abstract go to Japanese page English
Vol.39 No.9 2006 September [Table of Contents] [Full text ( PDF 483KB)]
CASE REPORT

5-Fluorouracil-Based Chemotherapy for Unresectable Small Bowel Adenocarcinoma: A Case Report

Kazuhito Minami, Yoshiyuki Yamaguchi*, Yasuhiro Tutani, Takahisa Suzuki, Eiji Miyahara, Akira Kameda and Yoshihiro Noso

Department of Surgery, Saiseikai Hiroshima Hospital
Department of Surgical Oncology, Research Institute for Radiation Biology
and Medicine, Hiroshima University*

A 74-year-old female was admitted because of nausea and vomiting due to obstraction of the proximal jejunum. She was diagnosed as having a malignant tumor in the small bowel with an upper gastro-intestinal series and a computerized tomography (CT) examination. Intra-operative findings showed that the primary tumor located in the proximal jejunum 2 cm to the anal side from Treitz's ligament, was 8 cm in size, had invaded the transverse colon, transverse mesocolon, and stomach, had had no liver metastasis, but had spread into the peritoneal cavity (T4NxM1, AJCC Stage IV). Pathological examination of the peritoneal seeding samples confirmed this lesion as a tubular adenocarcinoma. A bypass operation with gastro-jejunostomy and transverse-sigmoid colostomy was performed. She received palliative chemotherapy with 2 courses of low-dose 5-fluorouracil and cisplatin (low-dose FP) treatment followed by oral TS-1 therapy. A partial response in the primary tumor was acquired after the first course of low-dose FP treatment and maintained with TS-1 therapy, as assessed by CT examination. The progression-free survival was 25 months. Adverse effects for low-dose FP treatment were grade 3 stomatitis, dermatitis, nausea, vomiting, and anorexia and grade 2 neutropenia, but for TS-1 therapy were no adverse effects except for grade 1 neutropenia and pigmentation, indicating a good quality of life. This case may be important for developing a standard chemotherapy against advanced and recurrent adenocarcinoma of the small bowel.

Key words
small bowel adenocarcinoma, low-dose FP treatment, oral TS-1 therapy

Jpn J Gastroenterol Surg 39: 1523-1528, 2006

Reprint requests
Kazuhito Minami Department of Surgery, Saiseikai Hiroshima Hospital
2-3-10 Kita-shinchi, Saka-cho, Aki-Gun, 731-4311 JAPAN

Accepted
February 22, 2006

go to download site To read the PDF file you will need Abobe Reader installed on your computer.
return to the head of this page
back to main navigation
Copyright © The Japanese Society of Gastroenterological Surgery